Literature DB >> 3120919

Life threatening interaction between tamoxifen and warfarin.

R Lodwick, B McConkey, A M Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3120919      PMCID： PMC1248224          DOI： 10.1136/bmj.295.6606.1141-b

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  2 in total

1.  Tamoxifen and arterial thrombosis.

Authors:  R Dahan; M Espie; L Mignot; D Houlbert; B Chanu
Journal:  Lancet       Date:  1985-03-16       Impact factor: 79.321

2.  Acquired factor VIII deficiency in an elderly woman on tamoxifen.

Authors:  A H Barlas
Journal:  J Am Geriatr Soc       Date:  1986-04       Impact factor: 5.562
  2 in total
  12 in total

Review 1.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

2.  Quantitative studies of allosteric effects by biointeraction chromatography: analysis of protein binding for low-solubility drugs.

Authors:  Jianzhong Chen; David S Hage
Journal:  Anal Chem       Date:  2006-04-15       Impact factor: 6.986

3.  Life threatening interaction between tamoxifen and warfarin.

Authors:  P Tenni; D L Lalich; M J Byrne
Journal:  BMJ       Date:  1989-01-14

Review 4.  Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.

Authors:  Balazs I Bodai; Phillip Tuso
Journal:  Perm J       Date:  2015

Review 5.  Comparative tolerability of first-generation selective estrogen receptor modulators in breast cancer treatment and prevention.

Authors:  M G Curtis
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

6.  The effect of anastrozole on the single-dose pharmacokinetics and anticoagulant activity of warfarin in healthy volunteers.

Authors:  R A Yates; J Wong; M Seiberling; M Merz; W März; M Nauck
Journal:  Br J Clin Pharmacol       Date:  2001-05       Impact factor: 4.335

Review 7.  Clinically significant drug interactions with the oral anticoagulants.

Authors:  M D Freedman; A G Olatidoye
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 8.  Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  M M Buckley; K L Goa
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

Review 9.  Antineoplastic agents. Drug interactions of clinical significance.

Authors:  E van Meerten; J Verweij; J H Schellens
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

Review 10.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.